Mangalam Drugs and Organics Ltd. (MANGALAM)
Market Open
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
27. 28
+0.09
+0.331%
₹
2.1B Market Cap
- P/E Ratio
2% Div Yield
22,062 Volume
- Eps
₹ 27.19
Previous Close Want to track MANGALAM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
MANGALAM trading today higher at ₹27.28, an increase of 0.331% from yesterday's close, completing a monthly decrease of -3.0561% or -₹0.86. Over the past 12 months, MANGALAM stock lost -5.5402%.
MANGALAM is not paying dividends to its shareholders.
The last earnings report, released on May 15, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Mangalam Drugs and Organics Ltd. has completed 1 stock splits, with the recent split occurring on Nov 29, 2016.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
MANGALAM Chart
Mangalam Drugs and Organics Ltd. (MANGALAM) FAQ
What is the stock price today?
The current price is ₹27.28.
On which exchange is it traded?
Mangalam Drugs and Organics Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is MANGALAM.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2%.
What is its market cap?
As of today, the market cap is 2.1B.
Has Mangalam Drugs and Organics Ltd. ever had a stock split?
Mangalam Drugs and Organics Ltd. had 1 splits and the recent split was on Nov 29, 2016.
Mangalam Drugs and Organics Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | XNSE Exchange | INE584F01014 ISIN |
| India Country | 523 Employees | 21 Dec 2017 Last Dividend | 29 Nov 2016 Last Split | - IPO Date |
Overview
Mangalam Drugs & Organics Limited, founded in 1972 and based in Mumbai, India, is a leading manufacturer and supplier of active pharmaceutical ingredients (APIs) and intermediates. The company plays a significant role in the pharmaceutical industry by providing a wide range of vital products that cater to various therapeutic areas. Over the years, Mangalam Drugs & Organics Limited has established itself as a reputable entity in both the domestic and international markets, emphasizing quality, compliance, and innovation in its manufacturing processes.
Products and Services
Mangalam Drugs & Organics Limited offers an extensive portfolio of products and services, including:
- Active Pharmaceutical Ingredients (APIs): The company manufactures a wide range of APIs such as Acyclovir, Amodiaquine, Artemether, Artesunate, and Atazanavir Sulfate, among others. These APIs are essential for producing various medications that treat conditions like malaria, HIV, heart diseases, and more.
- Intermediates: Intermediates such as 2-Dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-Dichloro-5-methoxy pyrimidine; and 4,7 Dichloroquinoline are part of their product range. These intermediates are crucial for the synthesis of more complex compounds and APIs, serving the pharmaceutical industry's needs for component substances in drug formulation.
- Specialty Chemicals: The company's specialty chemicals include Menthol, 2,3-Dihydrophthalazine-1, 4-dione, and 4-cynoethyl-2-methyl phenol. Such chemicals find applications beyond the pharmaceutical industry, in sectors like food and beverage, personal care, and more, showcasing the company's versatility and expansive expertise in chemical synthesis.
- Products Under Development: Mangalam is continuously expanding its offerings by developing new products such as Tafenoquine Succinate, Bictegravir Na, Favipiravir, and Molnupiravir, along with Elvitegravir, Cobicistat, Daclatasvir dihydrochloride, Ledipasvir, and Velpatasvir. This focus on innovation and development ensures the company remains at the forefront of addressing emerging health challenges and market demands.
Contact Information
Address: Rupam Building
Phone: 91 22 6261 6200
Website: https://www.mangalamdrugs.com
